Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study
暂无分享,去创建一个
N. Hinata | M. Miyake | K. Numakura | Y. Kawasaki | H. Miyake | Y. Matsushita | Takuma Kato | T. Sazuka | Tomohiko Ichikawa | Hajime Tanaka | Toshifumi Kurahashi | Takahiro Kimura | Shingo Hatakeyama | Kosuke Ueda | Kazutoshi Fujita | Takahiro Osawa | Hiroshi Kitamura | Takahiro Kojima | Hiroaki Sato | Masayuki Takahashi